Read Now

By submitting this form, you agree to our Terms of Use, you accept our use of cookies, and you have read and accept our Privacy Policy.

state of pharma 2018

For the pharmaceutical industry, the past year was challenged with a new administration that was both unpredictable and unconventional, a new FDA commissioner, and high levels of scrutiny surrounding drug prices and opioid use. This eBook offers current insight on:

  • Opioid crisis aftermath: how are pharma manufacturers and regulators dealing? 
  • Pharma Career and Salary Survey results
  • Regulatory intelligence: the most impactful regulatory initiatives from the past year